NCT04732104View on ClinicalTrials.gov

Efficacy of Lidocaine and Xylometazoline Intranasal Spray in Anesthetizing Maxillary Teeth

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

August 14, 2020

Conditions
Effect of Drug
Interventions
DRUG

Lidocaine topical

intranasal spray anesthesia will be administered for achieving pulpal local anesthesia of maxillary anterior and premolar teeth. Xylometazoline OTC decongestant will be used to prolong the duration of anesthesia

DRUG

Lidocaine Hydrochloride

injectable local anesthesia will be administered to achieve pulpal local anesthesia of maxillary anterior and premolar teeth

Trial Locations (1)

Unknown

Dow University of Health Sciences, Karachi

All Listed Sponsors
lead

Dow University of Health Sciences

OTHER

NCT04732104 - Efficacy of Lidocaine and Xylometazoline Intranasal Spray in Anesthetizing Maxillary Teeth | Biotech Hunter | Biotech Hunter